239 related articles for article (PubMed ID: 35105803)
1. BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer.
Liu B; Liu X; Han L; Chen X; Wu X; Wu J; Yan D; Wang Y; Liu S; Shan L; Zhang Y; Shang Y
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35105803
[TBL] [Abstract][Full Text] [Related]
2. LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer.
Li M; Liu M; Han W; Wang Z; Han D; Patalano S; Macoska JA; Balk SP; He HH; Corey E; Gao S; Cai C
Cancer Res; 2023 May; 83(10):1684-1698. PubMed ID: 36877164
[TBL] [Abstract][Full Text] [Related]
3. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
4. Prox1 directly interacts with LSD1 and recruits the LSD1/NuRD complex to epigenetically co-repress CYP7A1 transcription.
Ouyang H; Qin Y; Liu Y; Xie Y; Liu J
PLoS One; 2013; 8(4):e62192. PubMed ID: 23626788
[TBL] [Abstract][Full Text] [Related]
5. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.
Wang Y; Zhang H; Chen Y; Sun Y; Yang F; Yu W; Liang J; Sun L; Yang X; Shi L; Li R; Li Y; Zhang Y; Li Q; Yi X; Shang Y
Cell; 2009 Aug; 138(4):660-72. PubMed ID: 19703393
[TBL] [Abstract][Full Text] [Related]
6. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
[TBL] [Abstract][Full Text] [Related]
7. The Homeotic Protein SIX3 Suppresses Carcinogenesis and Metastasis through Recruiting the LSD1/NuRD(MTA3) Complex.
Zheng Y; Zeng Y; Qiu R; Liu R; Huang W; Hou Y; Wang S; Leng S; Feng D; Yang Y; Wang Y
Theranostics; 2018; 8(4):972-989. PubMed ID: 29463994
[TBL] [Abstract][Full Text] [Related]
8. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation.
Whyte WA; Bilodeau S; Orlando DA; Hoke HA; Frampton GM; Foster CT; Cowley SM; Young RA
Nature; 2012 Feb; 482(7384):221-5. PubMed ID: 22297846
[TBL] [Abstract][Full Text] [Related]
9. Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer.
Liu J; Duan Z; Guo W; Zeng L; Wu Y; Chen Y; Tai F; Wang Y; Lin Y; Zhang Q; He Y; Deng J; Stewart RL; Wang C; Lin PC; Ghaffari S; Evers BM; Liu S; Zhou MM; Zhou BP; Shi J
Nat Commun; 2018 Dec; 9(1):5200. PubMed ID: 30518851
[TBL] [Abstract][Full Text] [Related]
10. Opposing Functions of BRD4 Isoforms in Breast Cancer.
Wu SY; Lee CF; Lai HT; Yu CT; Lee JE; Zuo H; Tsai SY; Tsai MJ; Ge K; Wan Y; Chiang CM
Mol Cell; 2020 Jun; 78(6):1114-1132.e10. PubMed ID: 32446320
[TBL] [Abstract][Full Text] [Related]
11. LSD1 coordinates with the SIN3A/HDAC complex and maintains sensitivity to chemotherapy in breast cancer.
Yang Y; Huang W; Qiu R; Liu R; Zeng Y; Gao J; Zheng Y; Hou Y; Wang S; Yu W; Leng S; Feng D; Wang Y
J Mol Cell Biol; 2018 Aug; 10(4):285-301. PubMed ID: 29741645
[TBL] [Abstract][Full Text] [Related]
12. Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes.
Dooley KE; Warburton A; McBride AA
mBio; 2016 Sep; 7(5):. PubMed ID: 27624132
[TBL] [Abstract][Full Text] [Related]
13. ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.
Nagarajan S; Rao SV; Sutton J; Cheeseman D; Dunn S; Papachristou EK; Prada JG; Couturier DL; Kumar S; Kishore K; Chilamakuri CSR; Glont SE; Archer Goode E; Brodie C; Guppy N; Natrajan R; Bruna A; Caldas C; Russell A; Siersbæk R; Yusa K; Chernukhin I; Carroll JS
Nat Genet; 2020 Feb; 52(2):187-197. PubMed ID: 31913353
[TBL] [Abstract][Full Text] [Related]
14. The histone demethylase LSD1 regulates inner ear progenitor differentiation through interactions with Pax2 and the NuRD repressor complex.
Patel D; Shimomura A; Majumdar S; Holley MC; Hashino E
PLoS One; 2018; 13(1):e0191689. PubMed ID: 29370269
[TBL] [Abstract][Full Text] [Related]
15. NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.
Marques JG; Gryder BE; Pavlovic B; Chung Y; Ngo QA; Frommelt F; Gstaiger M; Song Y; Benischke K; Laubscher D; Wachtel M; Khan J; Schäfer BW
Elife; 2020 Aug; 9():. PubMed ID: 32744500
[TBL] [Abstract][Full Text] [Related]
16. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
17. An epigenetic switch regulates de novo DNA methylation at a subset of pluripotency gene enhancers during embryonic stem cell differentiation.
Petell CJ; Alabdi L; He M; San Miguel P; Rose R; Gowher H
Nucleic Acids Res; 2016 Sep; 44(16):7605-17. PubMed ID: 27179026
[TBL] [Abstract][Full Text] [Related]
18. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
[TBL] [Abstract][Full Text] [Related]
19. Translational isoforms of FOG1 regulate GATA1-interacting complexes.
Snow JW; Orkin SH
J Biol Chem; 2009 Oct; 284(43):29310-9. PubMed ID: 19654328
[TBL] [Abstract][Full Text] [Related]
20. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
